Free access

Research Article

20 May 2022

An impact evaluation of an education bundle for patients at risk of developing venous thromboembolism

Authors: Nicole Boyer https://orcid.org/0000-0003-3371-917X [email protected], Robert Skinner https://orcid.org/0000-0002-0195-2121, and Andrew Breck https://orcid.org/0000-0003-0950-5796Author Info & Affiliations

Publication: Journal of Comparative Effectiveness Research

Volume 11, Number 8

https://doi.org/10.2217/cer-2021-0260

PDF OtherFormats

Abstract

Aim: Among hospitalized patients, venous thromboembolism (VTE) is a preventable cause of morbidity and mortality. This study analyzed the effects of a large-scale adoption of a prompt response and education protocol to increase VTE prophylaxis adherence in the USA. Methods: A Markov model was developed that simulates outcomes and costs of delivering a VTE education bundle versus not, to hospitalized at-risk patients. Results: The education bundle could avert more than 134,000 VTEs, 552,000 hospital days and 19,000 deaths over 5 years. Patients could save 13 million hours in work absenteeism and travel time, valued at US$237 million. Total societal savings could amount to US$2.8 billion. In scenario analyses with assumed lower-effectiveness estimates, the bundle averts 16,000 VTEs, 67,000 hospital days and 2000 deaths. Conclusion: A nationwide rollout of an education bundle to reduce missed doses of prescribed prophylaxis could improve quality of care, resulting in a decline in VTEs and mortality.

Plain language summary

In a previous study, an education bundle was designed to increase administration of medication to prevent blood clotting among hospitalized patients at risk of venous thromboembolism (VTE). The education bundle led to a decrease in patients missing those needed doses of medication. The current study estimates the economic impacts of a nationwide rollout of the education bundle for patients at risk of VTE. The results show that if the education bundle were rolled out nationally, it could result in 134,000 fewer VTEs, 552,000 fewer days spent in the hospital and 19,000 fewer deaths over 5 years. As a result of reduced medical care, less time off work, and informal caregiving needed, societal cost savings could be as much as US$2.8 billion.

Supplementary Material

File (supplementary materials (2).docx)

Download
29.56 KB

References

Papers of special note have been highlighted as: • of interest; •• of considerable interest

1.

Heit JA, Crusan DJ, Ashrani AA, Petterson TM, Bailey KR. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US. Blood 130(2), 109–114 (2017).

2.

Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb. Res. 137, 3–10 (2016).

•• Demonstrates the economic burden of venous thromboembolism.

3.

Alotaibi GS, Wu C, Senthilselvan A, McMurtry MS. Secular trends in incidence and mortality of acute venous thromboembolism: the AB-VTE population-based study. Am. J. Med. 129(8), 879.e19–879.e25 (2016).

4.

Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch. Intern. Med. 159(5), 445–453 (1999).

5.

Schünemann HJ, Cushman M, Burnett AE et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2(22), 3198–3225 (2018).

6.

Louis SG, Sato M, Geraci T et al. Correlation of missed doses of enoxaparin with increased incidence of deep vein thrombosis in trauma and general surgery patients. JAMA Surg. 149(4), 365–370 (2014).

• Finds a link between missed doses of prophylaxis and deep vein thrombosis.

7.

Lau BD, Wang J, Hobson DB et al. Missed doses of venous thromboembolism prophylaxis: a growing problem without an active management strategy. J. Gen. Intern. Med. 36(2), 540–542 (2021).

8.

Fanikos J, Stevens LA, Labreche M et al. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am. J. Med. 123(6), 536–541 (2010).

9.

Streiff MB, Lau BD, Hobson DB et al. The Johns Hopkins Venous Thromboembolism Collaborative: multidisciplinary team approach to achieve perfect prophylaxis. J. Hosp. Med. 11(Suppl. 2), 8–14 (2016).

10.

Haut ER, Aboagye JK, Shaffer DL et al. Effect of real-time patient-centered education bundle on administration of venous thromboembolism prevention in hospitalized patients. JAMA Netw. Open 1(7), e184741 (2018).

•• Demonstrating an increase in prophylaxis administration due to decreased patient refusal because of the education bundle.

11.

Johns Hopkins Medicine. How do I prevent blood clots? YouTube [Video]. (2015). www.youtube.com/watch?v=0o3yadu4DFw

12.

Murphy PB, Vogt KN, Lau BD et al. Venous thromboembolism prevention in emergency general surgery: a review. JAMA Surg. 153(5), 479–486 (2018).

13.

Haut ER, Lau BD, Kraus PS et al. Preventability of hospital-acquired venous thromboembolism. JAMA Surg. 150(9), 912–915 (2015).

•• Attempts to measure the preventability of venous thromboembolism by measuring patients with defect-free care.

14.

U.S. Bureau of Economic Analysis. Personal consumption expenditures: health (chain-type price index). FRED, Federal Reserve Bank of St. Louis [Web page] (2021). https://fred.stlouisfed.org/series/DHLTRG3A086NBEA

15.

Anderson FAJ, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am. J. Hematol. 82(9), 777–782 (2007).

16.

Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J. Manag. Care Spec. Ph. 13(6), 475–486 (2007).

17.

Cohoon KP, Leibson CL, Ransom JE et al. Direct medical costs attributable to venous thromboembolism among persons hospitalized for major operation: a population-based longitudinal study. Surgery 157(3), 423–431 (2015).

18.

Owodunni OP, Haut ER, Shaffer DL et al. Using electronic health record system triggers to target delivery of a patient-centered intervention to improve venous thromboembolism prevention for hospitalized patients: is there a differential effect by race? PLoS One 15(1), e0227339 (2020).

19.

Bureau of Labor Statistics. Software Developers, Quality Assurance Analysts, and Testers (2020). www.bls.gov/ooh/computer-and-information-technology/software-developers.htm

20.

Quality, Certificationand Oversight Reports. Hospitals: Active Provider and Supplier Counts Report. https://qcor.cms.gov/hospital_wizard.jsp?which=3&report=active.jsp

21.

Bureau of Labor Statistics. Labor Force Statistics from the Current Population Survey (2020). www.bls.gov/cps/

22.

Bliss RL, Katz JN, Wright EA, Losina E. Estimating proximity to care: are straight line and zipcode centroid distances acceptable proxy measures? Med. Care 50(1), 99–106 (2012).

23.

Internal Revenue Service. Standard Mileage Rates www.irs.gov/tax-professionals/standard-mileage-rates

24.

Voils SA, Carlson A. Association of deep-vein thrombosis (DVT) with missed doses of prophylactic antithrombotic medications in ICU patients: a case-control study. Ann. Pharmacother. 48(10), 1294–1297 (2014).

25.

Lau BD, Haut ER. Practices to prevent venous thromboembolism: a brief review. BMJ Qual. Saf. 23(3), 187–195 (2014).

26.

Ginsberg JS, Hirsh J, Julian J et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch. Intern. Med. 161(17), 2105–2109 (2001).

27.

Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester venous thromboembolism study. Arch. Intern. Med. 168(4), 425–430 (2008).

28.

Healthcare Cost and Utilization Project. Free Health Care Statistics (2014). https://hcupnet.ahrq.gov

29.

Tsai J, Abe K, Boulet SL, Beckman MG, Hooper WC, Grant AM. Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism. PLoS One 8(7), e70061 (2013).

30.

Centers for Medicare & Medicaid Services. Medicare Part D Drug Spending Dashboard [Dataset] (2020). https://data.cms.gov/summary-statistics-on-use-and-payments/medicare-medicaid-spending-by-drug/medicare-part-d-spending-by-drug

31.

Shahi A, Chen AF, Tan TL, Maltenfort MG, Kucukdurmaz F, Parvizi J. The incidence and economic burden of in-hospital venous thromboembolism in the United States. J. Arthroplasty 32(4), 1063–1066 (2017).

32.

Agency for Health Research and Quality. MEPS HC-201: 2017 Full Year Consolidated Data File [Dataset] (2019). https://meps.ahrq.gov/mepsweb/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-201

33.

Wolff JL, Roter DL. Family presence in routine medical visits: a meta-analytical review. Soc. Sci. Med. 72(6), 823–831 (2011).

|